best supportive care


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia, Wikipedia.

best supportive care

Ideal patient care, e.g., health care that meets the patient's nutritional, philosophical, psychological, physical, medical, surgical, and social needs.
See also: care
References in periodicals archive ?
4 months versus similar survival with best supportive care followed by crossover to panitumumab at progression.
Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC).
RECOURSE is a randomized, double-blind, placebo-controlled Phase III trial that compares TAS-102 with best supportive care (BSC) to investigate the efficacy and safety of TAS-102 when administered to patients with advanced recurrent colorectal cancer that is both unresectable and relapsed/refractory to standard chemotherapies.
injection) plus best supportive care as compared to placebo plus best
In a study conducted by the National Cancer Institute of Canada (NCIC) and the Australasian Gastro-Intestinal Trials Group, 572 patients who had failed two previous rounds of chemotherapy were randomized to receive either best supportive care alone or best supportive care plus cetuximab.
Na) to best supportive care, designed to determine the efficacy and safety of rigosertib in higher-risk MDS patients with excess blasts (5% to 30% bone marrow blasts), who are refractory, intolerant to, or have relapsed after azacitidine or decitabine treatment.
gov identifier: NCT02149108] is a double-blind, randomized, placebo-controlled study designed to evaluate the safety and efficacy of nintedanib plus best supportive care (BSC), versus placebo plus BSC, after previous treatment with standard chemotherapy and biological agents.
The results of the pivotal Phase III GRID study showed that regorafenib plus best supportive care (BSC) significantly improved progression-free survival (PFS) compared to placebo plus BSC (HR=0.
This is the first randomized controlled phase III study comparing a monoclonal antibody with best supportive care in chemoresistant patients," Dr.
Patients will be randomized 2:1 to receive either CRLX101 plus best supportive care or best supportive care, respectively.
everolimus) tablets plus best supportive care (BSC) compared to placebo plus BSC in patients with well-differentiated advanced and progressive pancreatic neuroendocrine tumors (pNET)[sup.